Pfizer 4Q Revenues: $13.1 billion (+4%) 4Q Earnings: $2.9 billion (-70%) FY Revenues: $48.6 billion (+1%) FY Earnings: $8.3 billion (-57%) Comments: Pharmaceutical revenues for the quarter were $11.9 billion, up 2% thanks to favorable foreign exchange, which increased revenues by approximately $550 million or 5%. FY pharma revenues were $44.6 billion, down 1%. Lipitor revenues in the quarter were $3.4 billion, up 3%, but were down 2% for the year, at $12.7 billion. 4Q Celebrex sal...